Natural Capsules P/B Ratio
Natural Capsules (NATCAPSUQ) P/B ratio is 0.7 (Low), book value per share ₹257.00 vs Healthcare average P/B of -0.93 — Low - Trading below book value, may indicate undervaluation. For live price, earnings yield and the full fundamental profile, see NATCAPSUQ screener.
Current Valuation Metrics
Book Value Breakdown (2025)
Valuation Signal
Sector Context
NATCAPSUQ P/B Ratio — Valuation Insights & Book Value Analysis
Natural Capsules price-to-book ratio interpretation, valuation status and historical context — current P/B 0.7 (Low). View NATCAPSUQ 52-week chart for the annual high/low range and current price position.
- Stock appears undervalued with PB of 0.7, trading below book value
- Trading below book value - potential value opportunity or financial distress signal
- Current PB is 69.4% below historical average
- Trading at premium to sector average PB of -0.93
Natural Capsules P/B Ratio Historical Trend
NATCAPSUQ annual price-to-book ratio — 5 years, book value per share and year-end price. P/B below 1.0 indicates the stock trades below net asset value. Compare with NATCAPSUQ DCF valuation to assess whether the stock is under or overvalued.
NATCAPSUQ Historical P/B Ratio — Book Value Per Share & Year-End Price
Natural Capsules annual P/B ratio, book value per share (₹), year-end price and total equity in ₹ Crores.
| Year | P/B Ratio | Book Value/Share (₹) | Year-end Price (₹) | Total Equity (₹ Cr) | Valuation |
|---|---|---|---|---|---|
| 2025 | 0.65 | ₹257.0 | ₹166.00 | ₹257 | Low |
| 2024 | 1.07 | ₹254.44 | ₹271.55 | ₹229 | Moderate |
| 2023 | 2.19 | ₹164.44 | ₹359.75 | ₹148 | Moderate |
| 2022 | 4.33 | ₹118.57 | ₹513.15 | ₹83 | High |
| 2021 | 3.21 | ₹103.33 | ₹331.50 | ₹62 | High |
NATCAPSUQ vs Healthcare Peers — P/B Ratio Comparison
Natural Capsules P/B 0.7 vs Healthcare average -0.93, median 0.6 — range -31.21–1.04.
| Company | Symbol | P/B Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Rekvina Laboratories | VINRKLB | -31.21 | ₹25 | Low |
| Sun Pharma Advanced Rese… | SPARC | -16.05 | ₹5,310 | Low |
| Span Divergent | SDL | -6.32 | ₹19 | Low |
| Oxygenta Pharmaceutical | OXYGENTAPH | -5.54 | ₹203 | Low |
| Satiate Agri | SATAGRI | -3.39 | ₹8 | Low |
| Adline Chem Lab | ADLINE | -3.03 | ₹5 | Low |
| Bharat Immunologicals | BIBCL | -2.31 | ₹75 | Low |
| Parmax Pharma | PARMAX | -2.16 | ₹12 | Low |
| Krebs Biochemicals & Ind… | KREBSBIO | -0.76 | ₹121 | Low |
| Cresanto Global | CRESANTO | -0.7 | ₹2 | Low |